Literature DB >> 15221629

Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.

M Avanzi1, E Uber, F Bonfà.   

Abstract

We describe two cases where increases in dopaminergic therapy were initiated by the patients due to perceived deterioration in symptoms of idiopathic Parkinson's disease. Shortly afterwards, both cases also met clinical criteria for pathological gambling. To date, only 29 cases of pathological gambling in patients with Parkinson's disease have been reported. This "pathological gambling disorder" is an addiction-like behavior triggered by excessive dopaminergic drugs and does not respond to standard therapy for pathological gambling. It only responds to an adjustment of Parkinson's disease therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221629     DOI: 10.1007/s10072-004-0238-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

Review 1.  Calculating utility: preclinical evidence for cost-benefit analysis by mesolimbic dopamine.

Authors:  Paul E M Phillips; Mark E Walton; Thomas C Jhou
Journal:  Psychopharmacology (Berl)       Date:  2006-11-22       Impact factor: 4.530

Review 2.  Antiparkinsonian medication and pathological gambling.

Authors:  Malcolm Lader
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  [Reversible pathological gambling under treatment with pramipexole].

Authors:  K Spengos; E Grips; G Karachalios; G Tsivgoulis; G Papadimitriou
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

4.  Impulsive behavior and associated clinical variables in Parkinson's disease.

Authors:  Aviva Abosch; Akshay Gupte; Lynn E Eberly; Paul J Tuite; Martha Nance; Jon E Grant
Journal:  Psychosomatics       Date:  2011 Jan-Feb       Impact factor: 2.386

Review 5.  Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.

Authors:  Angelo Antonini; Roberto Cilia
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

6.  Management of impulse control disorders in Parkinson's disease.

Authors:  Wendy R Galpern; Mark Stacy
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

7.  Nucleus accumbens neurons track behavioral preferences and reward outcomes during risky decision making.

Authors:  Jonathan A Sugam; Michael P Saddoris; Regina M Carelli
Journal:  Biol Psychiatry       Date:  2013-10-19       Impact factor: 13.382

8.  The four As associated with pathological Parkinson disease gamblers: anxiety, anger, age, and agonists.

Authors:  Michael A Shapiro; Yu Ling Chang; Sarah K Munson; Charles E Jacobson; Ramon L Rodriguez; Frank M Skidmore; Michael S Okun; Hubert H Fernandez
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

Review 9.  Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.

Authors:  Marie Grall-Bronnec; Anne Sauvaget; Fanny Perrouin; Juliette Leboucher; François Etcheverrigaray; Gaëlle Challet-Bouju; Louise Gaboriau; Pascal Derkinderen; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  J Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.